Navigation Links
Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
Date:10/27/2009

EAST RUTHERFORD, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) announced that third quarter 2009 financial results will be released on Tuesday, November 3, 2009 after the market closes.

The Company will host a conference call to discuss the third quarter 2009 financial results.

                     Third Quarter 2009 Earnings Conference Call

    When:            Wednesday, November 4, 2009 at 8:30 a.m. Eastern Time

    Dial-in:         1-888-634-4003 for U.S.
                     1-706-634-6653 for International
                     Pass code:  37211896

    Dial-in Replay:  1-800-642-1687 for U.S.
                     1-706-645-9291 for International
                     Pass code:  37211896
                     Available through Wednesday, November 11, 2009

    Webcast:         www.cambrex.com
                     Available for 30 days following the conference call

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. For more information, please visit www.cambrex.com.

SOURCE Cambrex Corporation


'/>"/>
SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Mount Elizabeth Novena Hospital will soon become the first ... treat cancer using the TrueBeam™ STx system for radiotherapy ... VAR ).  At a Grand Opening event last Friday, ... of treatment including radiosurgery, a precise method of using ... from outside the body, without performing surgery.  ...
(Date:3/2/2015)... -- Valencia Technologies Corporation (" Valencia ") ... small device for the treatment of high blood pressure ... double-blinded, controlled trial are compelling and provide the Company ... succeed in a large U.S. trial for FDA approval. ... Valencia has successfully raised more than 2.2 ...
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
Breaking Medicine Technology:Mount Elizabeth Novena Hospital to Deliver First TrueBeam STx Radiosurgery Treatments in Singapore 2Mount Elizabeth Novena Hospital to Deliver First TrueBeam STx Radiosurgery Treatments in Singapore 3Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
... OAKLAND, Tenn., Feb. 23, 2011 Plexus Biomedical Inc. ... the Food and Drug Administration to market the first ... vaginal childbirth. Hemorrhoids associated with vaginal delivery are a ... 1,000,000 pregnant women in the U.S. every year. ...
... 2011 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... investor conferences in March: Citi,s 2011 Global Healthcare Conference , ... Capital Markets, Healthcare Conference , Thursday, March 3, at ... Healthcare Conference , Wednesday, March 9, at 10:15 a.m. ET ...
Cached Medicine Technology:Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth 2
(Date:3/2/2015)... Dinner preparation and meal planning have ... of DinnerDork , a company that specializes ... thousands of busy customers. The company recently responded ... offer a total of 6 diverse meal plan ... recipes and comfort foods; Paleo Palette, which caters ...
(Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the ... this year, having officially opened its doors on March 2, ... honoring over 70 employees who started on Day 1 and ... approximately 400 original employees. The celebration will be a ... , This Four Seasons flagship resort, the first resort ...
(Date:3/2/2015)... 2015 A true renaissance man—some might call ... 1960s cult rock band Khazad Doom, has long inspired his ... persevere despite all odds. His motto throughout his life has ... or goal was before him. And that attitude, born amidst ... passed on to a new generation. , As Eadon knows, ...
(Date:3/2/2015)... Houston, TX (PRWEB) March 02, 2015 ... CV? How should physicians request references? When are interviews ... physicians analyze employment opportunities?, Both training and practicing physicians ... answers to these questions and more at the PracticeLink ... March 18. The drop-in Job Fair is from 5:30 ...
(Date:3/2/2015)... Many mainstream media outlets have run ... But how much of that news reporting is true? ... prevent measles, but whose youngsters later developed autism, will ... speakers comprised of professionals, clinicians, researchers, therapists, advocates, and ... and questions about the body and childhood health will ...
Breaking Medicine News(10 mins):Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Growing List of Professionals Gather for World’s Most Comprehensive Autism Conference in Chicago, May 2015 2
... professor of pharmacology and a member of UNC Lineberger ... Innovative Research Grants from Stand Up to Cancer, the ... The grants were announced during an event at ... Meeting 2011. SU2C,s Innovative Research Grants Program, which ...
... University of California, San Diego School of Medicine say a ... harsh or demanding conditions is exploited by cancer cells, which ... inflammatory response in them that can aid tumor growth. ... medicine and director of the Laboratory of Immunology at the ...
... 4 (HealthDay News) -- A minimally invasive treatment for ... among seniors -- appears to be as effective as ... take about two hours to perform, the newer alternative ... a catheter-enabled insertion of a tiny clothespin-like device, called ...
... of Medicine,s Cosimo Commisso, PhD, a postdoctoral fellow in ... The Pancreatic Cancer Action Network-American Association for Cancer Research ... research. Dr. Commisso was honored at the American Association ... 2-6, in Orlando, Florida. Dr. Commisso will receive ...
... that reign during relapses of an aggressive human leukemia are ... a paper published online on April 4 in the ... By comparing the DNA of cancer cells taken at the ... acute lymphoblastic leukemia (T-ALL), Jean Soulier and co-workers found that ...
... calculator can predict the risk of postoperative complications occurring for ... the March issue of the Journal of the American ... surgical decision-making and will help patients better understand what they ... bariatric operation. The study authors developed the risk ...
Cached Medicine News:Health News:Call of the riled 2Health News:Clamp Device for Leaky Heart Valve Seems Effective 2Health News:Clamp Device for Leaky Heart Valve Seems Effective 3Health News:NYU School of Medicine researcher receives Pancreatic Cancer Action Network- AACR fellowship 2Health News:New tool helps surgeons predict patients' risk of complications after bariatric operations 2
Shandon Microscope Slide Trays...
... is the first solid-state,photocoagulator to ... wavelengths. This advanced,laser system makes ... a red or green wavelength,during ... and ensures effective,patient results., For ...
... Gathering, managing, and transmitting data ... you were hired for. Dawnings ResultNet/Plus ... running your lab, not your communications ... with transmitting result data from largescale ...
... Horizon Cardiology Hemo is a comprehensive ... for the cath lab. Patient ... cardiac images and procedural information all ... patient record, eliminating repetitive data entry. ...
Medicine Products: